{"data":[{"accessionNo":"0001274173-26-000207","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001819790","issuerName":"TARSUS PHARMACEUTICALS, INC.","ticker":"TARS","cusip":"87650L103","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":2808796,"percentOfClass":6.5,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001172661-26-002032","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":"87650L103","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":3600000,"percentOfClass":8.46,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001172661-26-002032","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":"87650L103","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3600000,"percentOfClass":8.46,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001172661-26-002032","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":"87650L103","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":3600000,"percentOfClass":8.46,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001274173-26-000126","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001819790","issuerName":"TARSUS PHARMACEUTICALS, INC.","ticker":"TARS","cusip":"87650L103","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":2240963,"percentOfClass":5.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001137774-26-000101","formType":"SCHEDULE 13G/A","amendmentNo":20,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":"87650L103","securityClass":"Common","eventDate":"2026-03-31","reportingPerson":"PRUDENTIAL FINANCIAL INC","reportingCik":null,"personType":"HC","sharesOwned":1836321,"percentOfClass":4.3,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0000053417-26-000037","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001819790","issuerName":"TARSUS PHARMACEUTICALS INC","ticker":"TARS","cusip":"87650L103","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Jennison Associates LLC","reportingCik":null,"personType":"IA","sharesOwned":1712124,"percentOfClass":4,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0000102909-26-002452","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals Inc","ticker":"TARS","cusip":"87650L103","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001214659-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":1188624,"percentOfClass":2.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001214659-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":1188624,"percentOfClass":2.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001214659-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":784938,"percentOfClass":1.85,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001214659-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":345686,"percentOfClass":0.81,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001214659-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":43500,"percentOfClass":0.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001214659-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":14500,"percentOfClass":0.04,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001172661-25-004834","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":3000000,"percentOfClass":7.11,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001172661-25-004834","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3000000,"percentOfClass":7.11,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tars"},{"accessionNo":"0001172661-25-004834","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001819790","issuerName":"Tarsus Pharmaceuticals, Inc.","ticker":"TARS","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":3000000,"percentOfClass":7.11,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tars"}],"updatedAt":"2026-11-04T02:05:38.765Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tars","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}